Jeffrey M. Dayno
CIK 1615993 · PRESIDENT, CEO · last filed 2026-01-26
Jeffrey M. Dayno is a PRESIDENT, CEO who has filed 30 SEC Form 4 insider transactions across 2 companies since 2014. The most recent filing, for HRMY, was dated Jan 26, 2026. Across all open-market trades the lifetime net is −$5.5M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $448.0K across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$448.0K
2
30
-$5.49M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| HRMY | PRESIDENT, CEO | 13,000 | $34.46 | $448.0K | -$5.43M | 16 | 2026-01-26 |
| Zyla Life Sciences (EGLT) Delisted | Chief Medical Officer | 18,212 | — | — | -$57.9K | 14 | 2017-06-12 |
Recent Filings
30 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-01-26 | HRMY | Mixed | +13,061 | -$384.4K | EDGAR |
| 2025-12-17 | HRMY | Mixed | −5,933 | -$875.7K | EDGAR |
| 2025-01-28 | HRMY | Mixed | +5,933 | -$173.6K | EDGAR |
| 2025-01-23 | HRMY | Mixed | — | -$615.7K | EDGAR |
| 2024-01-26 | HRMY | Grant (A) | — | $0 | EDGAR |
| 2023-05-31 | HRMY | Grant (A) | — | $0 | EDGAR |
| 2023-05-30 | HRMY | Grant (A) | — | $0 | EDGAR |
| 2022-11-04 | HRMY | Mixed | — | -$777.0K | EDGAR |
| 2022-11-02 | HRMY | Mixed | — | -$703.3K | EDGAR |
| 2021-10-20 | HRMY | Mixed | — | -$637.9K | EDGAR |